ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Prof Eggermont hosts a press conference at ESMO 2014 about the Cancer Core Europe initiative, which looks to collate data and research from six key European cancer centres to create a fully integrated and collaborative 'e-hospital'.
Here, Prof Zenz gives an overview of the National Center for Tumor Diseases in Heidelberg, Germany and its place within the Cancer Core Europe initiative.
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Synthetic biology and precision medicine in blood and gynaecological cancers
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
The Southeast Asian Breast Cancer Symposium; background, aims and successes
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
Choosing Wisely to mitigate financial toxicity in cancer care in Africa